Dithiocarbamates effectively inhibit the alpha-carbonic anhydrase from Neisseria gonorrhoeae
dc.contributor.author | Giovannuzzi, Simone | en |
dc.contributor.author | Abutaleb, Nader S. | en |
dc.contributor.author | Hewitt, Chad S. | en |
dc.contributor.author | Carta, Fabrizio | en |
dc.contributor.author | Nocentini, Alessio | en |
dc.contributor.author | Seleem, Mohamed N. | en |
dc.contributor.author | Flaherty, Daniel P. | en |
dc.contributor.author | Supuran, Claudiu T. | en |
dc.date.accessioned | 2022-08-24T17:13:04Z | en |
dc.date.available | 2022-08-24T17:13:04Z | en |
dc.date.issued | 2022-01-01 | en |
dc.description.abstract | Recently, inorganic anions and sulphonamides, two of the main classes of zinc-binding carbonic anhydrase inhibitors (CAIs), were investigated for inhibition of the alpha-class carbonic anhydrase (CA, EC 4.2.1.1) from Neisseria gonorrhoeae, NgCA. As an extension to our previous studies, we report that dithiocarbamates (DTCs) derived from primary or secondary amines constitute a class of efficient inhibitors of NgCA. K(I)s ranging between 83.7 and 827 nM were measured for a series of 31 DTCs that incorporated various aliphatic, aromatic, and heterocyclic scaffolds. A subset of DTCs were selected for antimicrobial testing against N. gonorrhoeae, and three molecules displayed minimum inhibitory concentration (MIC) values less than or equal to 8 mu g/mL. As NgCA was recently validated as an antibacterial drug target, the DTCs may lead to development of novel antigonococcal agents. | en |
dc.description.notes | CTS thank the Italian Ministry for University and Research (MIUR), project FISR2019_04819 BacCAD. The research program was partially funded by a Purdue Institute for Drug Discovery Programmatic Grant (to M.N.S. and D.P.F.) and NIH/NIAID 1R01AI148523 (to M.N.S and D.P.F.). Fabrizio Carta (F~C.) is grateful to "Bando di Ateneo per il Finanziamento di Progetti Competitivi per Ricercatori a Tempo Determinato (RTD) dell'Universita di Firenze" 2020-202100, and Fondazione Cassa di Risparmio di Firenze (Grant Number ECR2018.1001) for partially supporting this work. | en |
dc.description.sponsorship | Italian Ministry for University and Research (MIUR) [FISR2019_04819 BacCAD]; Purdue Institute for Drug Discovery Programmatic Grant; NIH/NIAID [1R01AI148523]; Fondazione Cassa di Risparmio di Firenze [ECR2018.1001]; "Bando di Ateneo per il Finanziamento di Progetti Competitivi per Ricercatori a Tempo Determinato (RTD) dell'Universita di Firenze" [2020-202100] | en |
dc.description.version | Published version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1080/14756366.2021.1988945 | en |
dc.identifier.eissn | 1475-6374 | en |
dc.identifier.issn | 1475-6366 | en |
dc.identifier.issue | 1 | en |
dc.identifier.pmid | 34894954 | en |
dc.identifier.uri | http://hdl.handle.net/10919/111622 | en |
dc.identifier.volume | 37 | en |
dc.language.iso | en | en |
dc.publisher | Taylor & Francis | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Carbonic anhydrase | en |
dc.subject | inhibitor | en |
dc.subject | dithiocarbamate | en |
dc.subject | Neisseria gonorrhoeae | en |
dc.subject | antibacterials | en |
dc.title | Dithiocarbamates effectively inhibit the alpha-carbonic anhydrase from Neisseria gonorrhoeae | en |
dc.title.serial | Journal of Enzyme Inhibition and Medicinal Chemistry | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 14756366.2021.pdf
- Size:
- 2.75 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version